SEC Info - Asterias Biotherapeutics, Inc. - ‘8-K’ for 6/30/14

SEC Info℠

Home

Help

Please Sign In

Asterias Biotherapeutics, Inc. – ‘8-K’ for 6/30/14 – EX-16.1

On: Monday, 7/7/14, at 5:22pm ET · For: 6/30/14 · Accession #: 1140361-14-27888 · File #: 0-55046

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 7/07/14  Asterias Biotherapeutics, Inc.    8-K:4,9     6/30/14    2:24K                                    Summit Fin’l Printing

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Asterias Biotherapeutics, Inc. 8-K 6-30-2014 (Oum)  HTML     20K 
 2: EX-16.1     Letter re: Change in Certifying Accountant          HTML      5K

EX-16.1 — Letter re: Change in Certifying Accountant

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit 16.1

July 7, 2014

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549-7561

Ladies and Gentlemen:

We have read Asterias Biotherapeutics, Inc.’s statements included under Item 4.01 of its Form 8-K dated June 30, 2014, and are in agreement with the statements contained therein concerning our Firm in response to Item 304(a) of Regulation S-K.

Very truly yours,

/s/Rothstein Kass

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on:	7/7/14
For Period End:	6/30/14	10-Q
		List all Filings

↑Top

Filing Submission 0001140361-14-027888 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)